Comparative Evaluation of Intravenous Dexmedetomidine with Ketamine and Intravenous Dexmedetomidine with Fentanyl in Facilitating Intubating Conditions During Awake Fiberoptic Intubation: A Prospective Randomised Double Blind Comparative Study
International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)
DOI: 10.25258/ijcpr.18.6.244 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Shrikrishna Chaudhary und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background and aims: Awake fiberoptic intubation (AFOI) is the gold standard for managing an anticipated difficult airway. Adequate sedation is crucial to ensure patient cooperation, suppress airway reflexes and provide haemodynamic stability. While dexmedetomidine is a preferred agent for AFOI due to its unique "cooperative sedation" profile, it can cause bradycardia and hypotension. Combining it with an opioid like fentanyl or a dissociative agent like ketamine may mitigate these side effects and improve intubating conditions. This study aimed to compare the efficacy of intravenous (IV) dexmedetomidine with ketamine versus IV dexmedetomidine with fentanyl in facilitating intubating conditions during AFOI. Methods: In this prospective, randomized, double blind study, 64 ASA I/II patients undergoing elective surgery were allocated into two groups (n=32 each). After nebulization with 4ml of 4% lignocaine, Group DF received IV dexmedetomidine (1 mcg/kg over 15min) followed by IV fentanyl (2 mcg/kg over 5min) and Group DK received IV dexmedetomidine (1 mcg/kg over 15min) followed by IV ketamine (40 mg over 5 min). All patients then underwent AFOI. The primary objective assessed was cough score. Secondary objectives included intubating conditions, vocal cord position, haemodynamic parameters, sedation, patient satisfaction and time for intubation. Categorical and continuous data were presented as number (proportion) and mean ± standard deviation respectively. Chi-square test and t-test were applied where deemed appropriate. P
Zitieren
APA
Chaudhary, S., Jain, A., Sharma, S., Choudhary, S., Singh, P., & Kumari, I. (2026). Comparative Evaluation of Intravenous Dexmedetomidine with Ketamine and Intravenous Dexmedetomidine with Fentanyl in Facilitating Intubating Conditions During Awake Fiberoptic Intubation: A Prospective Randomised Double Blind Comparative Study. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.244
Vancouver
Chaudhary S, Jain A, Sharma S, Choudhary S, Singh P, Kumari I. Comparative Evaluation of Intravenous Dexmedetomidine with Ketamine and Intravenous Dexmedetomidine with Fentanyl in Facilitating Intubating Conditions During Awake Fiberoptic Intubation: A Prospective Randomised Double Blind Comparative Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.244
BibTeX
@article{Chaudhary2026,
author = {Chaudhary, Shrikrishna and Jain, Anush and Sharma, Sandeep and Choudhary, Santosh and Singh, Prakriti and Kumari, Indira},
title = {Comparative Evaluation of Intravenous Dexmedetomidine with Ketamine and Intravenous Dexmedetomidine with Fentanyl in Facilitating Intubating Conditions During Awake Fiberoptic Intubation: A Prospective Randomised Double Blind Comparative Study},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {06},
doi = {10.25258/ijcpr.18.6.244}
}
EUVIMED